The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain

Costa, Barbara, Trovato, Anna Elisa, Comelli, Francesca, Giagnoni, Gabriella, Colleoni, Mariapia·2007·European Journal of Pharmacology

Cited by (396)

Items 201–300 of 396

  1. Considerations for Cannabis Use to Treat Pain in Sickle Cell Disease
    Donovan Alexander Argueta, Anupam Aich, Fjolla Muqolli, Hemanth M. Cherukury, Varun Sagi, Nicholas Vincent DiPatrizio, Kalpna Gupta · 2020 · Journal of Clinical Medicine
  2. Exploring the Therapeutic Potential of Berberine and Tocopherol in Managing Diabetic Neuropathy: A Comprehensive Approach towards Alleviating Chronic Neuropathic Pain
    Faisal K. Alkholifi, Alhussain H. Aodah, Ahmed Ibrahim Foudah, Aftab Alam · 2023 · Biomedicines
  3. The thalidomide analgesic effect is associated with differential TNF-α receptor expression in the dorsal horn of the spinal cord as studied in a rat model of neuropathic pain
    Pablo Andrade, Veerle E. R. M. Visser-Vandewalle, John Smith Del Rosario, Marc A. R. C. Daemen, Wim A. Buurman, Harry W.M. Steinbusch, Govert Hoogland · 2012 · Brain Research
  4. Antinociception mechanisms of action of cannabinoid-based medicine: an overview for anesthesiologists and pain physicians
    Samer Narouze · 2020 · Regional Anesthesia & Pain Medicine
  5. Expression of cannabinoid (CB1 and CB2) and cannabinoid-related receptors (TRPV1, GPR55, and PPARα) in the synovial membrane of the horse metacarpophalangeal joint
    Rodrigo Zamith Cunha, Augusta Zannoni, Giulia Salamanca, Margherita De Silva, Riccardo Rinnovati, Alessandro Gramenzi, Monica Forni, Roberto Chiocchetti · 2023 · Frontiers in Veterinary Science
  6. Cannabidiol as an Antioxidant
    Rosivaldo S. Borges, Albérico B. F. da Silva · 2017 · Elsevier eBooks
  7. Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
    Sherelle L. Casey, Christopher Walter Vaughan · 2018 · Medicines
  8. Plasma and joint tissue pharmacokinetics of two doses of oral cannabidiol oil in guinea pigs (Cavia porcellus)
    Alexa P. Spittler, Joel E. Helbling, Stephanie McGrath, Daniel L. Gustafson, Kelly S. Santangelo, Miranda J. Sadar · 2021 · Journal of Veterinary Pharmacology and Therapeutics
  9. Impact of conformational and solubility properties on psycho-activity of cannabidiol (CBD) and tetrahydrocannabinol (THC)
    Vitor A. N. Bragança, Tiago Galan de França, Ana Carolina S. P. S. de Jesus, Ivanete Cardoso Palheta, Fernanda P. A. Melo, Paulo Alexandre P. F. G. das Neves, Anderson H. Lima, Rosivaldo S. Borges · 2020 · Chemical Data Collections
  10. Cannabidiol and its application in the treatment of oral diseases: therapeutic potentials, routes of administration and prospects
    Zonghao Hu, Zishun Qin, Jinhong Xie, Yue Qu, Lihua Yin · 2024 · Biomedicine & Pharmacotherapy
  11. Topical Cannabidiol for Established Chemotherapy-Induced Neuropathy: A Pilot Randomized Placebo-Controlled Trial
    Stacy D. D’Andre, Paul Novotny, Camille Walters, Susie Lewis-Peters, Stephan D. Thomé, Cindy Tofthagen, Karthik V. Giridhar, Charles L. Loprinzi · 2024 · Cannabis and Cannabinoid Research
  12. Preinjury Use of Marijuana and Outcomes in Trauma Patients
    Sharven Taghavi, Saul Ramirez, Juan Carlos Duchesne, Danielle M. Tatum · 2020 · Journal of Surgical Research
  13. Cannabidiol attenuates hypersensitivity and oxidative stress after traumatic spinal cord injury in rats
    Verónica Baron-Flores, Araceli Dı́az-Ruiz, Jorge Manzanares, Camilo Rı́os, Masha Burelo, Gustavo Jardón-Guadarrama, María de los Ángeles Martínez-Cárdenas, Alfonso Mata-Bermúdez · 2022 · Neuroscience Letters
  14. Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence
    Eddy E. Sokolaj, Neda Assareh, Kristen E. Anderson, Karin R. Aubrey, Christopher Walter Vaughan · 2023 · Journal of Neurochemistry
  15. Assessing the Safety and Therapeutic Efficacy of Cannabidiol Lipid Nanoparticles in Alleviating Metabolic and Memory Impairments and Hippocampal Histopathological Changes in Diabetic Parkinson’s Rats
    Sarawut Lapmanee, Sakkarin Bhubhanil, Prapimpun Wongchitrat, Natthawut Charoenphon, Anjaree Inchan, Thitaphat Ngernsutivorakul, Piroonrat Dechbumroong, Mattaka Khongkow, Katawut Namdee · 2024 · Pharmaceutics
  16. Overlapping Mechanisms of Stress-Induced Relapse to Opioid Use Disorder and Chronic Pain: Clinical Implications
    Udi E. Ghitza · 2016 · Frontiers in Psychiatry
  17. Molecular signaling of synthetic cannabinoids: Comparison of CB1 receptor and TRPV1 channel activation
    Haley K. Andersen, Kenneth B. Walsh · 2021 · European Journal of Pharmacology
  18. Cannabidiol‐rich non‐psychotropic Cannabis sativa L. oils attenuate peripheral neuropathy symptoms by regulation of CB2 ‐mediated microglial neuroinflammation
    Vittoria Borgonetti, Lisa Anceschi, Virginia Brighenti, Lorenzo Corsi, Paolo Governa, Fabrizio Manetti, Federica Pellati, Nicoletta Galeotti · 2022 · Phytotherapy Research
  19. Cannabinoids and agmatine as potential therapeutic alternatives for cisplatin-induced peripheral neuropathy
    Başak Dönertaş, Çiğdem Çengelli Ünel, Kevser Erol · 2018 · Journal of Experimental Pharmacology
  20. Cannabidiol alleviates LPS ‐inhibited odonto/osteogenic differentiation in human dental pulp stem cells in vitro
    Chatvadee Kornsuthisopon, Ajjima Chansaenroj, Ravipha Suwittayarak, Suphalak Phothichailert, Khunakon Usarprom, Apicha Srikacha, Sornkanok Vimolmangkang, Chaloemrit Phrueksotsai, Lakshman Perera Samaranayake, Thanaphum Osathanon · 2024 · International Endodontic Journal
  21. Direct Regulation of Hyperpolarization-Activated Cyclic-Nucleotide Gated (HCN1) Channels by Cannabinoids
    Sultan Mayar, Mina Memarpoor‐Yazdi, Ahmad Makky, Romina Eslami Sarokhalil, Nazzareno D’Avanzo · 2022 · Frontiers in Molecular Neuroscience
  22. Comparative evaluation of ethyl acetate and n‐Hexane extracts of Cannabis sativa L. leaves for muscle function restoration after peripheral nerve lesion
    Javeria Maqbool, Haseeb Anwar, Azhar Rasul, Ali Imran, Malik Saadullah, Shoaib Ahmad Malik, Asghar Shabbir, Rabia Akram, Faiqa Sajid, Shamaila Zafar et al. · 2023 · Food Science & Nutrition
  23. SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy
    Nicolas Mandel, Michael Büttner, Gernot Poschet, Rohini Kuner, Nitin Agarwal · 2023 · Cells
  24. Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors
    Daniela Maria Escobar-Espinal, Airam Nicole Vivanco-Estela, Núbia Barros, Maurício dos Santos Pereira, Francisco Silveira Guimarães, Elaine Del Bel, Glauce Crivelaro Nascimento · 2024 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  25. Therapeutic Cannabis and Endocannabinoid Signaling System Modulator Use in Otolaryngology Patients
    Lucas M. Bryant, Kelly E. Daniels, David M. Cognetti, Patrick T. Tassone, Adam Luginbuhl, Joseph Curry · 2018 · Laryngoscope Investigative Otolaryngology
  26. Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention
    Eugene L. Scharf · 2017 · Cannabis and Cannabinoid Research
  27. Does cannabis alleviate tinnitus? A review of the current literature
    Vishal Narwani, Alexandra T. Bourdillon, Keerthana Nalamada, Richard Peter Manes, Douglas M. Hildrew · 2020 · Laryngoscope Investigative Otolaryngology
  28. Advances in the design and discovery of novel small molecule drugs for the treatment of Dravet Syndrome
    Barbara Miziak, Stanisław Jerzy Czuczwar · 2020 · Expert Opinion on Drug Discovery
  29. Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism
    Douglas Lamounier de Almeida, Renata Cristina Mendes Ferreira, Flávia Cristina de Sousa Fonseca, Daniel Portela Dias Machado, Danielle Diniz Aguiar, Francisco Silveira Guimarães, Igor Dimitri Gama Duarte, Thiago Roberto Lima Romero · 2024 · Nitric Oxide
  30. Unraveling the Mechanisms of Cannabidiol’s Pharmacological Actions: A Comprehensive Research Overview
    Iqra Kalsoom, Kiran Shehzadi, Hansheng Li, Hongliang Wen, Mingjia Yu · 2024 · Topics in Current Chemistry
  31. Cannabis sativa L. Extract Alleviates Neuropathic Pain and Modulates CB1 and CB2 Receptor Expression in Rat
    Joanna Bartkowiak-Wieczorek, Agnieszka Bienert, Kamila Czora-Poczwardowska, Radosław Kujawski, Michał Szulc, Przemysław Łukasz Mikołajczak, Anna-Maria Wizner, Małgorzata Jamka, Marcin Hołysz, Karolina Wielgus et al. · 2024 · Biomolecules
  32. Immunomodulatory Actions of Cannabinoids: Clinical Correlates and Therapeutic Opportunities for Allergic Inflammation
    Ajay P. Nayak, Cali Loblundo, Leonard Bielory · 2022 · The Journal of Allergy and Clinical Immunology In Practice
  33. IUPHAR review- Preclinical models of neuropathic pain: Evaluating multifunctional properties of natural cannabinoid receptors ligands
    Khalid Benamar · 2023 · Pharmacological Research
  34. Neferine alleviates P2X3 receptor in rat dorsal root ganglia mediated neuropathic pain
    Dan Yu, Hongmin Guo, Chaoran Zheng, Baoguo Wu, Jingjing Guo, Guilin Li · 2020 · Neuroscience Research
  35. Neuroprotective constituents from the aerial parts of Cannabis sativa L. subsp. sativa
    Jia Li, Guan Wang, Qin Yu, Xue Zhang, Haifeng Wang, Hongwei Liu, Lingjuan Zhu, Xin‐Sheng Yao · 2020 · RSC Advances
  36. Possible effects of cannabidiol (CBD) administration on the vocal activity of healthy domestic dogs upon their temporary separation from caregivers
    Nobuo Masataka · 2024 · Heliyon
  37. Is cannabidiol (CBD) effective to ease separation anxiety?
    Nobuo Masataka · 2024 · Heliyon
  38. Trends in Prevalence and Outcomes of Cannabis Use Among Chronic Obstructive Pulmonary Disease Hospitalizations: A Nationwide Population-Based Study 2005–2014
    Kulothungan Gunasekaran, Dinesh Chandra Voruganti, Mandeep Singh Rahi, Kalaimani Elango, Sathishkumar Ramalingam, Adiba Geeti, Jeff S. Kwon · 2021 · Cannabis and Cannabinoid Research
  39. Cannabis and the immune response: A comprehensive review of therapeutic potential and concerns
    Muna M. Barakat, Samar H. Thiab, Lujain F. Alzaghari, Shaymaa B. Abdulrazzaq, Eliza Hasen, Sara Feras Abuarab, Lara Nasereddin, Amin Omar, Yasmeen Barakat, Dinesh Kumar Chellappan et al. · 2025 · Phytomedicine Plus
  40. Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition
    Noemí Cárdenas‐Rodríguez, Iván Ignacio‐Mejía, José Correa‐Basurto, Humberto Carrasco-Vargas, Marco Antonio Vargas-Hernández, Exsal Manuel Albores Méndez, Rodolfo David Mayen-Quinto, Reynita De La Paz-Valente, Cindy Bandala · 2024 · International Journal of Molecular Sciences
  41. The Development of Cannabinoids as Therapeutic Agents in the United States
    Conor H. Murray, Brenda M. Gannon, Peter John Winsauer, Ziva D. Cooper, Marcus Sherode Delatte · 2024 · Pharmacological Reviews
  42. Chemotherapy-Induced Neuropathic Pain
    Robert B. Raffa, Richard M Langford, Joseph V. Pergolizzi, Frank Porreca, Ronald J. Tallarida · 2012 · CRC Press eBooks
  43. Enhancing Cannabichromenic Acid Biosynthesis in Saccharomyces cerevisiae
    Mingming Qi, Tian Liu, Wenqiang Zhang, Huihui Wan, Min Wang, Wei Kang, Chuang Xue · 2025 · ACS Synthetic Biology
  44. Cannabidiol reduces neuropathic pain and cognitive impairments through activation of spinal PPARγ
    Ana Mara Islas-Espinoza, Itzel I. Ramos-Rodríguez, María J Escoto-Rosales, Juan M. Pizaña-Encarnación, Diana Karen Morales-Galindo, Nadia L. Caram‐Salas, Myrna Déciga‐Campos, Erick Josué Rodríguez-Palma, Vinicio Granados‐Soto · 2025 · Journal of Pain
  45. The Mechanism of Cannabichromene and Cannabidiol Alone Versus in Combination in the Alleviation of Arthritis-Related Inflammation
    Graham Grogan, Kristen L. Stephens, Jesse Chou, Michael Paul Timko, Patrick S. Cottler, Brent R. DeGeorge · 2023 · Annals of Plastic Surgery
  46. Understanding the endocannabinoid system as a modulator of the trigeminal pain response to concussion
    Melanie B. Elliott, Sara Jane Ward, Mary E. Abood, Ronald F. Tuma, Jack Jallo · 2017 · Concussion
  47. The effects of cannabidiol on nitric oxide synthases: a narrative review on therapeutic implications for inflammation and oxidative stress in health and disease
    Seyed Amin Alavi Hooshmand, Maryam Rameshrad, Amirhossein Sahebkar, Mehrdad Iranshahi · 2025 · Journal of Cannabis Research
  48. Cannabidiol as a Modulator of the Development of Alcohol Tolerance in Rats
    Michał Szulc, Radosław Kujawski, Amanda Pacholak, Marta Poprawska, Kamila Czora-Poczwardowska, Bogna Geppert, Przemysław Łukasz Mikołajczak · 2023 · Nutrients
  49. Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors
    Robert C. Barnes, Satish Banjara, Melissa C. McHann, Sharilyn Almodóvar, Angela N. Henderson, Daniel J. Morgan, Isabel Castro‐Piedras, Josée Guindon · 2023 · Journal of Pharmacology and Experimental Therapeutics
  50. Effectiveness of the injectable hyaluronic acid-based microparticles loaded with cannabidiol on rat sciatic nerve injury model
    Seyed Mohammad Davachi, Marisol Vazquez, Maryam Soleimani, Zeinab Hajmohammadi, Maryam Mohajer, Seyed Behnamedin Jameie, Mehdi Khanmohammadi, Roghayeh Najafi, Zohre Bagher, Sajad Hassanzadeh · 2024 · International Journal of Biological Macromolecules
  51. Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models
    Sitthiphon Bunman, Sombat Muengtaweepongsa, Dilok Piyayotai, Ratthaphol Charlermroj, Korawit Kanjana, Sudtida Kaew-amdee, Manlika Makornwattana, Sang-Hyun Kim · 2023 · Cannabis and Cannabinoid Research
  52. Cannabinoids in Autoimmune and Rheumatic Diseases
    Luca Navarini, Domenico Paolo Emanuele Margiotta, Gabriele Gallo Afflitto, Antonella Afeltra · 2019 · Elsevier eBooks
  53. Cannabidiol and the central nervous system: translating into clinics
    A. Saviano, Federica Raucci, Martina Tallarico, C. De Caro, Stefania Martino, Valentina Nesci, Roberta Roberti, Luigi Francesco Iannone, A. L. Colia, S. Dimonte et al. · 2021
  54. 3D-Printed cannabidiol stent for local treatment of urinary tract infections
    Remo Eugster, Melanie Santschi, Giorgio Buttitta, Başak Olcay, Jean‐Louis Reymond, Simone Aleandri, Paola Luciani · 2025 · International Journal of Pharmaceutics
  55. Cannabis use amongst tinnitus patients: Consumption patterns and attitudes
    Dorsa Mavedatnia, Marc Levin, Jong Wook Lee, Amr F. Hamour, Kaye Dizon, Trung Le · 2023 · Journal of Otolaryngology - Head and Neck Surgery
  56. FDA-approved cannabidiol [Epidiolex®] alleviates Gulf War Illness-linked cognitive and mood dysfunction, hyperalgesia, neuroinflammatory signaling, and declined neurogenesis
    Maheedhar Kodali, Leelavathi Narayana Madhu, Venkata Sai Vashishta Kolla, Sahithi Attaluri, Charles Huard, Yogish Somayaji, Bing Shuai, Chase Jordan, Xiaolan Rao, Sanath Shetty et al. · 2024 · Military Medical Research
  57. Utilization of Cannabidiol in Post-Organ-Transplant Care
    幸子 小山, Jumar Etkins, Joshua Jun, Matthew Miller, Gerald C. So, Debora L. Gisch, Michael T. Eadon · 2025 · International Journal of Molecular Sciences
  58. Cannabidiol interactions with oxycodone analgesia in an operant orofacial cutaneous thermal pain assay following oral administration in rats
    Ariana C. Brice‐Tutt, Niall P Murphy, Barry Setlow, Alexandria S. Senetra, Wendi L. Malphurs, Robert M. Caudle, Adriaan W. Bruijnzeel, Marcelo Febo, Abhisheak Sharma, John K. Neubert · 2025 · Pharmacology Biochemistry and Behavior
  59. EVALUATION OF THERAPEUTIC POTENTIAL OF CANNABIDIOLBASED PRODUCTS IN ANIMAL MODELS OF EPILEPTIC SEIZURES, NEUROPATHIC PAIN AND CHRONIC INFLAMMATION
    Nicoleta Mirela Blebea · 2022 · FARMACIA
  60. Can cannabidiol have an analgesic effect?
    Bartłomiej Kulesza, Marek Mazurek, Jacek Kurzepa · 2023 · Fundamental and Clinical Pharmacology
  61. A journey through cannabidiol in Parkinson’s disease
    Elaine Del-Bel, Núbia Barros, Rafaela Aparecida Ponciano da Silva de Moraes, Bianca Andretto de Mattos, Thaís Antônia Alves-Fernandes, Lorena Borges de Abreu, Glauce Crivelaro Nascimento, Daniela Maria Escobar-Espinal, João Francisco Cordeiro Pedrazzi, Gabrielle A. Jacob et al. · 2024 · International review of neurobiology
  62. Can cannabidiol (CBD) help with low back pain?
    Bartłomiej Kulesza, Marek Mazurek, Jacek Kurzepa · 2023 · Annals of Agricultural and Environmental Medicine
  63. Protocol for a pragmatic trial of Cannabidiol (CBD) to improve chronic pain symptoms among United States Veterans
    Rachel S. Bergmans, Riley Wegryn‐Jones, Catherine Klida, Vivian Kurtz, Laura Thomas, David A. Williams, Daniel Joseph Clauw, KM Kidwell, Amy M. Bohnert, Kevin F. Boehnke · 2024 · BMC Complementary Medicine and Therapies
  64. Effect of genistein on the cerebellar cortex of adult male albino rats with streptozotocin-induced diabetes mellitus
    Ola A. Hussein · 2015 · The Egyptian Journal of Histology
  65. Cannabinoids and Pain: Mechanisms of Action
    Samer Narouze · 2021 · Springer eBooks
  66. Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor
    Kobra Tahermanesh, Sahar Hakimpour, Azam Govahi, Fariborz Keyhanfar, Abolfazl Mehdizadehkashi, Shahla Chaichian, Roya Shahriyaripour, Marziyeh Ajdary · 2022 · BioMed Research International
  67. Cannabidiol Treatment Shows Therapeutic Efficacy in a Rodent Model of Social Transfer of Pain in Pair-Housed Male Mice
    Lígia Renata Rodrigues Tavares, Leonardo Abdelnur Petrilli, Daniela Baptista‐de‐Souza, Lucas Canto‐de‐Souza, Cleopatra S. Planeta, Francisco Silveira Guimarães, Ricardo Luiz Nunes‐de‐Souza, Azair Canto‐de‐Souza · 2023 · Cannabis and Cannabinoid Research
  68. Distinct antinociceptive and conditioned behavioral effects are produced by individual cannabinoids and a cannabis-derived mixture
    Tamara M. Morris, Jessica A. Cucinello‐Ragland, Taylor J. Marks, Kayla Prevost, John Frazier Glenn, Gregory J. Davenport, Scott Edwards, Peter John Winsauer · 2023 · Pharmacology Biochemistry and Behavior
  69. Cannabidiol and Beta-Caryophyllene: Chronic inflammatory pain
    Mohammed Alnoud, Mohammad Shabir Hussain, Jose Rios, Emmanuel Franco, Justin Mills, Joshua Nwose, Maria Sophia Malbas, Hiram Garcia, Sophia Leslie, Manish Kumar Tripathi et al. · 2025 · Pharmacological Research
  70. Herbal therapies for pain management: a scoping review of the current evidence
    Md. Kamrul Hasan, Khwaja Zohura Zanzabil, Iffat Ara, Tania Rahman, Alexander Kieu, Linda Östlundh, Sameeha Junaidi, Moien AB Khan · 2024 · Phytochemistry Reviews
  71. Self-reported knowledge of tetrahydrocannabinol and cannabidiol concentration in cannabis products among cancer patients and survivors
    Michelle R. Goulette, Nicolas J. Schlienz, Amy Allen Case, Eric Hansen, Cheryl Rivard, Rebecca L. Ashare, Maciej Lukasz Goniewicz, Maansi Bansal‐Travers, Andrew J. Hyland, Danielle M. Smith · 2024 · Supportive Care in Cancer
  72. Morphine-induced side effects can be differentially modulated by cannabidiol in male and female rats
    Carlos Henrique Alves Jesus, Jaqueline Volpe, Bruna Bittencourt Sotomaior, Maria Augusta Ruy Barbosa, Matheus Vinícius Ferreira, Fernanda Fiatcoski, Karina Genaro, José Alexandre S. Crippa, Dênio Emanuel Pires Souto, Joice Maria da Cunha · 2024 · Behavioural Pharmacology
  73. Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via in vivo PET Imaging and Behavioral Assessment
    Yu‐Shin Ding, Jiacheng Wang, Vinay Kumar, James A. Ciaccio, Sami Dakhel, Cathy Shunwen Tan, Jonathan Kim, Sabrina Lee, Hilla Katz-Lichtenstein, Zakia Ben Youss et al. · 2022 · International Journal of Innovative Research in Medical Science
  74. Biodegradable cannabidiol: a potential nanotherapeutic for neuropathic pain
    Sana Qayum, Rebecca R. Schmitt, Janvhi Suresh Machhar, Sonali Garg, Caroline E. Bass, Vijaya Prakash Krishnan Muthaiah, Tracey A. Ignatowski, Supriya D. Mahajan · 2024 · NeuroImmune Pharmacology and Therapeutics
  75. Impact of an acute 1-month cannabidiol treatment on pain and inflammation after a long bone fracture: a triple-blind randomised, placebo-controlled, clinical trial protocol
    Daphnée Brazeau, Amelie A Deshaies, David R. Williamson, Francis Bernard, C. Arbour, A. Pinard, D. Rouleau, L. de Beaumont · 2025 · BMJ Open
  76. Industrial hemp decreases intestinal motility stronger than indian hemp in mice.
    Ana Sabo, Olga Horvat, Nebojša Stilinović, Janoš J. Berenji, Saša Vukmirović · 2013 · PubMed
  77. Cardiac Transplantation and the Use of Cannabis
    Hirak Shah, Meg Fraser, Arianne Clare Agdamag, Valmiki Maharaj, Bellony N. Nzemenoh, Cindy M. Martin, Tamás Alexy, Daniel J. Garry · 2021 · Life
  78. BIOCIDAL ACTIVITY OF Ag-PEG-CHITOSAN NANOCOMPOSITE FILM PREPARED USING CANNABIS SATIVA AQUEOUS LEAF EXTRACT BY SONICATION
    Garima Ameta, Pinki B. Punjabi · 2018 · European Chemical Bulletin
  79. The Reversal of Empathy-Induced Hypernociception in Male Mice by Intra-Amygdala Administration of Midazolam and Cannabidiol Depends on 5-HT 3 Receptors
    Lígia Renata Rodrigues Tavares, Daniela Baptista‐de‐Souza, Lucas Canto‐de‐Souza, Cleopatra S. Planeta, Francisco Silveira Guimarães, Ricardo Luiz Nunes‐de‐Souza, Azair Canto‐de‐Souza · 2022 · Cannabis and Cannabinoid Research
  80. [The potential use of cannabidiol in the therapy of metabolic syndrome].
    D. Kleiner, K. Ditrói · 2012 · Orvosi Hetilap
  81. Progress in study of Cannabis sativa leaves extracts without psychotropic cannabinoids in animal model of neuropathic pain
    Marcin Ożarowski, Przemysław Łukasz Mikołajczak, Anna Bogacz, Joanna Bartkowiak-Wieczorek, Radosław Kujawski, Marian Majchrzycki, Karolina Wielgus, Agnieszka Seremak‐Mrozikiewicz, Bogusław Czerny · 2014 · Journal of Medical Science
  82. Alternative & complementary treatment for pediatric inflammatory bowel disease
    Ramit Magen Rimon, Ron R. Shaoul · 2019 · Translational Pediatrics
  83. Cannabis, cannabinoids, and receptor responses
    Yi Yang, Roya Derwish, Lakshmi P. Kotra · 2023 · Elsevier eBooks
  84. Characterisation of components of an extract of hemp and preliminary assessment of anti-inflammatory activity in an ex vivo model of bovine endometritis
    Ifat Parveen, Nathan R. Allen, Ruth E. Wonfor, Ammar A. Al-Fadhli, Josephine Forde-Thomas, Joanna L. Giles, Robert T. Walton, Michael D. Threadgill, Deborah M. Nash · 2025 · South African Journal of Botany
  85. Cannabidiol Treatment in a Predator-Based Animal Model of PTSD: Assessing Oxidative Stress and Memory Performance
    George Jîtcă, Robert Stoicescu, Erzsébet Májai · 2025 · International Journal of Molecular Sciences
  86. Dietary Cannabidiol Supplementation on Growth Performance, Behavior, Blood Profile, Metabolomic Analysis, and Fatty Acid Composition in Rabbits: A Multi-Disciplinary Approach to Improve Welfare and Productivity
    Nicola Francesco Addeo, Valeria Iervolino, Ruggero Amato, Mariarosaria Lanzieri, Daria Lotito, Maria Vittoria Tignani, Alessia Staropoli, Sara Damiano, Pietro Lombardi, Francesco Vinale et al. · 2025 · Veterinary Sciences
  87. Neuroprotection by the cannabis-related products, cannabidiol and cannabigerol, and their associated mechanisms of action
    Carolina Echeverry, Jimena Fagetti, Miguel Iván Reyes-Parada, Cecilia Scorza · 2023 · Elsevier eBooks
  88. Therapeutic effect of cannabidiol on myocardial arachidonic acid content in various lipid fractions in a rat model of obesity
    Klaudia Sztolsztener, Wiktor Bzdęga, Karolina Konstantynowicz-Nowicka, Adrian Chabowski, Ewa Harasim‐Symbor · 2023 · Prostaglandins & Other Lipid Mediators
  89. Batch and Continuous Flow Total Synthesis of Cannabidiol
    Felipe C. Braga, Felipe L. N. da Silva, Tiago O. Ramos, João G. H. Rosa, Érica de A. Araujo, F. C. Nelson, Edison Perevalo Wendler, Adilson Beatriz, Rodrigo O. M. A. de Souza, Timothy J. Brocksom et al. · 2024 · Chemistry - An Asian Journal
  90. Zebrafish as a High-Throughput In Vivo Model for Testing the Bioactivity of Cannabinoids
    Lee Ellis · 2019 · IntechOpen eBooks
  91. Potential analgesic effect of a novel cannabidiol nanocrystals powder for the treatment of neuropathic pain
    Yu Wang, Xinzhen Fu, Meihua Zheng, Qian Liu, Hailin Gan, Zeyu Song, Mingyan Yang, Ke Liu, Zeping Xie, Huaying Fan · 2024 · European Journal of Pain
  92. Neuropathic Pain and Related Depression in Mice: The Effect of a Terpene and a Minor Cannabinoid in Combination
    Jose Rios, Mohammed Alnoud, Mohammad Shabir Hussain, Zayd Ayas, E. E. Franco, Justin Mills, Joshua Nwose, Maria Sophia Malbas, Hiram Garcia, Manish Kumar Tripathi et al. · 2025 · Biomedicines
  93. Repeated administration of cannabidiol decreases splenic lymphocyte subset numbers in rats
    T Turkki, Maciej M. Jankowski, Wojciech Glac, Piotr Badtke, Viviane M. Saito, Artur Hugo Swiergiel, Bogna Marta Ignatowska-Jankowska · 2026 · International Journal of Immunopathology and Pharmacology
  94. Anti-inflammatory and analgesic potential of minor cannabinoids in vivo
    S. Olivia Vanegas, Thomas F. Gamage, Jonathan Maturano, David Šarlah, S. G. Kinsey · 2026 · Journal of Cannabis Research
  95. Supercritical carbon dioxide Cannabis sativa L. and Humulus lupulus extracts and their influence on human macrophages inflammatory state*
    Aleksandra Gregorius, Wojciech Krzyczkowski, Marta Wierucka, Julia Kupińska, Agnieszka Dębczak, Urszula Łopatek, Katarzyna Tyśkiewicz, Rafał Wiejak, Olga Wrona, Edward Rój · 2019 · Postępy Higieny i Medycyny Doświadczalnej
  96. The therapeutic effect of the oily extract of Cannabis sp. in Aluminum Chloride-Induced Alzheimer's Disease in Rats
    Raíssa Nunes da Silva, Fernanda Carolina Ribeiro Dias, Sandra Maria de Torres, Alluanan Adelson do Nascimento Silva, Amanda de Deus Ferreira Alves, Antonio José Alves, Valdemiro Amaro da Silva · 2024 · Revista Eletrônica Acervo Saúde
  97. Optimal Delivery of Pain Management in Schwannomatosis: A Literature Review
    Utaro Hino, Ryota Tamura, Masahiro Toda · 2025 · Therapeutics and Clinical Risk Management
  98. RETRACTED: Possible Anxiolytic Effects of Cannabidiol (CBD) Administration on Feline Responses to a Fear Response Test
    Nobuo Masataka · 2025 · Animals · Retracted
  99. Possibilities of therapeutic action of cannabinoids in neurodegenerative diseases
    Anna Aleksandra Kaszyńska · 2022 · Pharmacotherapy in Psychiatry and Neurology
  100. Development of Raynaud Phenomenon Following Use of Medical Cannabis
    Jennifer Ben Shimol, Oded Sheinberg · 2020 · JCR Journal of Clinical Rheumatology